Article

RPB awards $4.8M in grants to supporteye research

New York-Research to Prevent Blindness (RPB), announced 44 new grants totaling $4.8 million for investigations into the causes, treatment, and prevention of all blinding diseases.

New York-Research to Prevent Blindness (RPB), announced 44 new grants totaling $4.8 million for investigations into the causes, treatment, and prevention of all blinding diseases.

In the past 18 months, RPB has committed more than $12.9 million to eye research.

Across the United States, RPB-supported laboratories are investigating the entire spectrum of eye disease: from cataract, glaucoma, and diabetic reti-nopathy to age-related macular degeneration, retinitis pigmentosa, and eye movement disorders.

The latest awards were given to 29 medical institutions, including unrestricted and challenge grants to depart-ments of ophthalmology at 22 medical schools and 22 awards to individual scientists.

The recently-approved grant projects include:

Among RPB's vision scientists fighting eye diseases are nine active Jules and Doris Stein RPB Professors who receive $375,000 each over 5 years and up to $100,000 in a matching grant for laboratory construction.

An additional $150,000 may be awarded during a 2-year extension of the award.

RPB currently supports eye research at 54 medical institutions throughout the United States.

For a complete listing of grant recipients, go to http://www.rpbusa.org. OT

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.